Phase 3 study of recombinant von Willebrand factor in patients with severe von Willebrand disease who are undergoing elective surgery: Comment
J Thromb Haemost
.
2019 Aug;17(8):1403-1405.
doi: 10.1111/jth.14472.
Author
Wolfgang Miesbach
1
Affiliation
1
Haemophilia Centre, Medical Clinic II, Institute of Transfusion Medicine, Goethe University Hospital, Frankfurt am Main, Germany.
PMID:
31058403
DOI:
10.1111/jth.14472
No abstract available
Publication types
Letter
Comment
MeSH terms
Elective Surgical Procedures
Factor VIII
Humans
von Willebrand Diseases*
von Willebrand Factor
Substances
von Willebrand Factor
Factor VIII